Berberis Vulgaris Consumption and Blood Pressure
- Conditions
- Blood PressureLipid ProfileCardiovascular Risk Factor
- Interventions
- Dietary Supplement: berberis vulgaris=barberryDietary Supplement: Placebo
- Registration Number
- NCT04084847
- Lead Sponsor
- Shahid Beheshti University
- Brief Summary
The aim of this study is to investigate the effect of barberry consumption on systolic and diastolic blood pressure, serum lipids, and inflammatory status. The study will involve cases having elevated BP (129/ \< 85) and known hypertensive patients on medical treatment. Seventy people will be randomized into two groups, including intervention (barberry) or placebo groups.
Before and after of 8 week intervention, 24-hour ambulatory blood pressure monitoring will be done and fasting venous blood sample will be taken to measure plasma lipids. In addition, 24-hour urine will be collected to measure its sodium content and estimate sodium intake.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 78
- willingness to participate in the study
- age between 20-65 years
- having elevated BP (129/ < 85) and known hypertensive patients on medical treatment
- at least one other classical cardiovascular disease risk factors, including hyperlipidemia or diabetes mellitus
- Unwillingness to continue participation
- BMI> 30
- patients on nitrates
- high doses of statins consumption (Atorvastatin>40 mg/day or Rosuvastatin>20 mg/day)
- consumption of vitamins or minerals supplements during past month
- Chronic kidney disease stage 4 or 5
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Barberry berberis vulgaris=barberry Daily consumption of barberry in powder form. placebo Placebo Daily consumption of placebo powder.
- Primary Outcome Measures
Name Time Method blood pressure at 8 weeks mean of systolic and diastolic blood pressure of participants measured by ambulatory 24 hour blood pressure monitoring
- Secondary Outcome Measures
Name Time Method lipid profile at 8 weeks plasma TC, LDL-C, HDL-C, TG
plasma NOx at 8 weeks concentration of nitrite and nitrate in plasma
Inflammatory cytokine at 8 weeks Plasma Interleukin-6
Trial Locations
- Locations (1)
Rajaei Cardiovascular, Medical & Research Center
🇮🇷Tehran, Iran, Islamic Republic of